Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma

Background. Nuclear shape analysis of histologic sections from radical prostatectomy specimens has retrospectively predicted outcome in patients with clinically localized prostate carcinoma. If outcome could be predicted preoperatively by nuclear shape analysis, patients might be selected better for definitive surgical therapy. Morphometric analysis of preoperative biopsies, however, has not correlated positively with values obtained from analysis of prostatectomy specimens.

[1]  E. Jaffee,et al.  Demonstration of a rational strategy for human prostate cancer gene therapy. , 1994, The Journal of urology.

[2]  P. Walsh,et al.  Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. , 1993, The Journal of urology.

[3]  A. Partin,et al.  The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma. , 1993, The Journal of urology.

[4]  A. Partin,et al.  Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma. , 1992, Analytical and quantitative cytology and histology.

[5]  A. Partin,et al.  Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy. , 1992, The Journal of urology.

[6]  A. Partin,et al.  Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease‐free survival among patients with prostate cancer , 1992, Cancer.

[7]  A. Partin,et al.  The use of nuclear morphometry to predict response to therapy in Wilms' tumor , 1992, Cancer.

[8]  A. Partin,et al.  Prediction of prognosis in untreated stage A2 prostatic carcinoma , 1992, Cancer.

[9]  T. Stamey,et al.  Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarcinoma of the prostate , 1992, Cancer.

[10]  H. Zincke,et al.  Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation) , 1991, The Journal of urology.

[11]  A. Partin,et al.  Nuclear shape analysis for assessment of prognosis in renal cell carcinoma. , 1990, The Journal of urology.

[12]  A W Partin,et al.  A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. , 1989, The Journal of urology.

[13]  A. Partin,et al.  Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. , 1989, The Journal of urology.

[14]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[15]  A W Partin,et al.  Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. , 1988, The Journal of urology.

[16]  A W Partin,et al.  Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of a digitization system. , 1988, The Journal of urology.

[17]  C. R. Bagnell,et al.  Nuclear roundness factor: A quantitative approach to grading in prostatic carcinoma, reliability of needle biopsy tissue, and the effect of tumor stage on usefulness , 1987, The Prostate.

[18]  D. Paulson,et al.  Radical prostatectomy: anatomical predictors of success or failure. , 1986, The Journal of urology.

[19]  T. Stamey,et al.  PATTERNS OF PROGRESSION IN PROSTATE CANCER , 1986, The Lancet.

[20]  J. Epstein,et al.  Nuclear roundness factor. A predictor of progression in untreated stage A2 prostate cancer , 1984, Cancer.

[21]  J. Epstein,et al.  Squamous carcinoma of the foot arising in association with long‐standing verrucous hyperplasia in a patient with congenital lymphedema , 1984, Cancer.

[22]  J C Eggleston,et al.  A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. , 1982, The Journal of urology.

[23]  C. Brendler,et al.  Experience with Gleason's histopathologic grading in prostatic cancer. , 1980, The Journal of urology.

[24]  G. Murphy,et al.  Histologic grading of primary prostatic cancer: a new approach to an old problem. , 1980, The Journal of urology.

[25]  Jewett Hj.  The present status of radical prostatectomy for stages A and B prostatic cancer. , 1975 .

[26]  F. Schröder,et al.  The TNM classification of prostate cancer , 1992, The Prostate. Supplement.

[27]  S. Mills,et al.  Operable prostatic carcinoma: correlations among clinical stage, pathological stage, gleason histological score and early disease-free survival. , 1985, The Journal of urology.

[28]  N. Bolton,et al.  Nuclear androgen receptors in the epithelium and stroma of human benign prostatic hypertrophic glands , 1983, The Prostate.

[29]  D. S. Coffey,et al.  Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer , 1982, The Prostate.

[30]  F. Mostofi,et al.  Grading of prostatic carcinoma. , 1975, Cancer chemotherapy reports.